Distribution of bronchoalveolar cells and fibronectin levels in bronchoalveolar lavage fluids from patients with lung disorders

References

• Fulmer J D, Crystal R G. Interstitial lung disease. Current Pulmonology, D E Simmons. Houghton Mifflin, Boston 1979; 1: 1–65
   Google Scholar
• Rennard S I, Bitterman P B, Crystal R G. Pathogenesis of granulomatous lung diseases. IV. Mechanisms of fibrosis. Am Rev Respir Dis 1984; 130: 492–6
   Google Scholar
• Crystal R G, Bitterman P B, Rennard S I, Hance A J, Keogh B A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310: 154–66
   PubMed Web of Science ®Google Scholar
• Christner P, Fein A, Goldberg S, Lippman M, Abrams W, Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 131: 690–5
   PubMed Web of Science ®Google Scholar
• O'Connor C, Odium C, van Breda A, Power C, Fitzgerald M X. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax 1988; 43: 393–400
   PubMed Web of Science ®Google Scholar
• Alitalo K, Hovi T, Vaheri A. Fibronectin is produced by human macrophages. J Exp Med 1980; 151: 602–13
   PubMed Web of Science ®Google Scholar
• Bianco C. Fibrin, fibronectin and macrophages. Ann NY Acad Sci 1983; 602–9
   Google Scholar
• Rennard S I, Hunninghake G W, Bitterman P B, Crystal R G. Production of fibronectin by the human alveolar macrophage: Mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci 1981; 78: 7147–51
   PubMed Web of Science ®Google Scholar
• Carrington C B, Gaensler E A, Mikus J P, Schachtcr A W, Burke G W, Golf A M. Structure and function in sarcoidosis. Ann NY Acad Sci 1976; 278: 265–83
   PubMed Web of Science ®Google Scholar
• Spencer H. Interstitial pneumonia. Ann Rev Med 1967; 18: 423–42
   PubMed Web of Science ®Google Scholar
• Bitterman P B, Adelberg S, Crystal R G. Mechanisms of pulmonary fibrosis: spontaneous release of alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest 1983; 72: 1801–13
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Keski-Oja J, Balian G, Kang A H. induction of fibroblast chemotaxis by fibronectin; localization of the chemotactic region to a 140,000-molccular weight non-gelatin binding fragment. J Exp Med 1981; 153: 494–9
   PubMed Web of Science ®Google Scholar
• Rennard S, Hunninghake G, Davis W, Mortiz E, Crystal R. Macrophage fibronectin is 1000-fold more potent as a fibroblast chemo-attractant than plasma fibronectin. Clin Res 1982; 30: 356, (abstract)
   Google Scholar
• Saba T M, Jaffe E. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 1980; 68: 577–94
   PubMed Web of Science ®Google Scholar
• Bitterman P B, Rennard S I, Adelberg S, Crystal R G. Role of fibronectin as a growth factor for fibroblasts. J Cell Biol 1983; 97: 1925–32
   PubMed Web of Science ®Google Scholar
• Rennard S I, Crystal R G. Fibronectin in human bronchopulmonary lavage fluid. J Clin Invest 1981; 69: 113–22
   Web of Science ®Google Scholar
• Yam L T, Li C Y, Crosby W H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971; 55: 283–90
   PubMed Web of Science ®Google Scholar
• Bensley S H. Pinacyanol erythrosinate as a stain for mast cells. Stain Technol 1952; 27: 269–73
   PubMed Web of Science ®Google Scholar
• Galdal K S, Evensen S A, Nilscn E. The effect of thrombin on fibronectin in cultured human endothelial cells. Thromb Res 1985; 37: 583–93
   Google Scholar
• Anderson R J, Sternberg J C. A rate nephelometer for immunoprecipitin measurement of specific serum proteins. Automated immunoanalysis. Marcel Dekker, New York 1978; 409–69, Part One.
   Google Scholar
• Haslam P L, Turton C WG, Heard B, Lukoszek A, Collins J V, Salsbury A J, Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: Comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35: 9–18
   PubMed Web of Science ®Google Scholar
• Reynolds H Y. Interstitial lung diseases: Classification, definition and correlation between clinical and histologic staging of interstitial lung diseases. Semin Respir Med 1984; 6: 1–9
   Google Scholar
• Reynolds H Y. Bronchoalveolar lavage. Am Rev Respir Dis 1987; 135: 250–63
   PubMed Web of Science ®Google Scholar
• Torikata C, Villiger B, Kuhn C, III, McDonald J A. Ultrastructural distribution of fibronectin in normal and fibrotic human lung. Lab Invest 1985; 52: 399–408
   PubMed Web of Science ®Google Scholar
• Jaffe E A, Mosher D F. Synthesis of fibronectin by cultured human endothelial cells. J Exp Med 1978; 147: 1779–91
   PubMed Web of Science ®Google Scholar
• Stenman S, Vaheri A. Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med 1978; 147: 1054–64
   PubMed Web of Science ®Google Scholar
• Rossman M D, McDonald J A, Brocckelmann T, Dauber J H, Daniele R P. Protein leak in pulmonary sarcoidosis: assessment of bronchoalveolar lavage fluid and plasma albumin and fibronectin. Am Rev Respir Dis 1983; 127: 90, (abstract)
   Google Scholar
• Rennard S, Bitterman P, Hunninghake G, Gadek J, Crystal R. Alveolar macrophage fibronectin: a possible mediator of tissue remodelling in fibrotic lung disease. Clin Res 1981; 29: 374, (abstract)
   Google Scholar
• Håkansson L, Venge P. The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J Immunol 1985; 135: 2735–9
   PubMed Web of Science ®Google Scholar
• Marino J A, Pensky J, Culp L A, Spagnuolo P J. Fibronectin mediates chemotactic factor-stimulated neutrophil substrate adhesion. J Lab Clin Med 1985; 105: 725–30
   Google Scholar
• Grinnell F, Feld M, Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata; requirement for cold-insoluble globulin (plasma fibronectin). Cell 1980; 19: 517–25
   PubMed Web of Science ®Google Scholar
• Colvin R B, Dvorak H F. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol 1975; 114: 377–87
   PubMedGoogle Scholar
• Clark R AF, Dvorak H F, Colvin R B. Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. J Immunol 1981; 126: 787–93
   PubMed Web of Science ®Google Scholar
• Clark R AF, Della Pelle P, Dvorak H F, Colvin R B. Fibronectin: a tissue matrix protein associated with fibroblast, epithelial cell and endothelial cell migration during wound healing. Clin Res 1981; 29: 590, (abstract)
   Google Scholar
• Nakstad B, Boye N P, Lyberg T. Procoagulant activities in human alveolar macrophages. Eur J Respir Dis 1987; 71: 459–71
   PubMedGoogle Scholar
• Chapman H A, Fair D S, Allen C L, Stone O L. Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest 1985; 75: 2030–7
   PubMed Web of Science ®Google Scholar
• McGee M P, Rothberger H. Tissue factor in bronchoalveolar lavage fluids. Evidence for an alveolar macrophage source. Am Rev Respir Dis 1985; 131: 331–6
   PubMed Web of Science ®Google Scholar